ARCHIVES

Shuttle Vector Technology Concept Approved

This article is from The Cancer Letter archive.

Vol. 12 No. 09 | February 28, 1986

Download PDF Visit The Full Archive

Related Articles

ACS Board Ok’s $93 Mil. Research Grants Budget, Society’s Largest Ever

March 27, 1992

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Reauthorization Battle Warms Up; Administration, But Not Wyngaarden, May OK Cancer Act Renewal

March 18, 1988

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007